Please Wait.....
Report
Native Collagen Market By Source (Bovine, Porcine, Poultry, Marine, Others), By Application (Healthcare and Pharmaceuticals, Cosmetics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-09-01 I 330 Pages I Allied Market Research
The global native collagen market size was valued at $305.2 million in 2021, and projected to reach $555.1 million by 2031, with a CAGR of 6.2% from 2022 to 2031.
Collagen has versatile properties that enable it to be extensively used in various industrial applications such as medical, cosmetics, and food & beverages. Hence, increasing application of collagen in the pharmaceutical and cosmetics industry is expected to fuel the demand for collagen products.
Cosmetics application accounted for over 24% of the market share in 2021. Collagen is a structural protein found in animal organisms where it provides for the fundamental structural support. Most commonly it is extracted from mammalian and fish skin. Collagen has attracted significant academic interest as well as the attention of the cosmetic industry due to its interesting properties that include being a natural humectant and moisturizer for the skin. Native collagen-based haircare products help reduce hair thinning and offer protection against sun damage. In addition, it promotes hair growth and boosts scalp hydration. The native collagen market players engage in continuous R&D activities to develop innovative products. They are also increasingly incorporating marine-based native collagen to boost product reach. For instance, COBIOSA produces native marine collagen for hair and skincare applications.
China population is aging faster than almost all countries in modern history. According to census released in 2020 18.7% of China population have people aged 60, and people aged 65 and above accounted for 13.5%. It is estimated that by 2050 the proportion of Chinese over retirement age will become 39% of the total population. In India, according to National Commission of Population report estimated that nearly 138 million elderly people are living in India in 2021. Thus, the growth rate of elderly population is higher than that of the general population. The presence of elderly people in developing countries require nutritional care and health care products increases the demand for native collagen. The gradual rise in awareness among the people living in this region regarding the importance of native collagen to aging people will drive the demand for market. In addition, lack of awareness among the people regarding the native collagen products is hampering the development of the market in this region. Moreover, rapid change in lifestyle and increase in per capita income of the middle class people will also have positive impact on the market.
Changing lifestyles, food habits, adoption of western food habits, an increase in demand for functional ingredients in food products, and an increase in industrial activity leading to the need for process enhancement have contributed to the development of the collagen market in emerging economies. Emerging economies such as the Asia Pacific, South Africa, the Middle East, South America, and Eastern European countries provide excellent opportunities for the growth of the market.
The global native collagen market is segmented on the basis of by source, application and region.
On the basis of source, it is segmented into bovine, porcine, poultry, marine, and others. In addition, on the basis of application, the global Native collagen market is segmented into healthcare and pharmaceuticals, cosmetics, and others. Furthermore, healthcare and pharmaceuticals segment is further bifurcated into bone and joint reconstruction, wound dressing, tissue regeneration, and others.
Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. Presently, North America accounts for the largest share of the market, followed by Asia-Pacific and Europe.
The major companies profiled in this report includes Aviva Systems Biology Corporation, Beyond Biopharma Co., Ltd., Bioiberica S.A.U., Bio-Rad Laboratories, Inc., Cosmo Bio, Creative Enzymes, RayBiotech, Inc., REPROCELL Inc., Rockland Immunochemicals Inc., Symatese, TSI Group Ltd., and Vetoquinol S.A. Additional growth strategies such as expansion of production capacities, acquisition, partnership and research & innovation in the extraction technologies have led to attain key developments in the global native collagen market trends.
Impact of Covid-19 on Global Native Collagen Market
The global COVID-19 pandemic has negative impact on the native collagen market. This market has experienced lower than anticipated demand across all regions compared to pre pandemic levels. The global market has exhibited a decline about 25% in 2020 compared to 2019 due to shutdown of various food processing industries and agricultural activities from where feedstock is used as raw material for the production.
The demand for products with a high nutritive value that offers multiple health benefits increases. Collagen is widely used in supplements targeted toward the aging population. The demand for collagen-based supplements by the aging population is anticipated to increase health, immunity, and overall wellness. Moreover, due to increasing health concerns due to pandemics, consumers now focus on food and beverage product labels. This is projected to provide ample opportunities for pharmaceuticals and healthcare products. The outbreak of pandemic is forecasted to affect the daily operations of collagen manufacturing due to restrictions on transportation and a shortage of laborers. However, the pandemic is anticipated to boost the sales of collagen during the study period, as it attracts attention from health-conscious consumers of different end products in which collagen is used, such as food, beverages, and nutritional products.
Post pandemic crisis, major collagen manufacturers have invested in the development of various products related to native collagen in cosmetics, pharmaceuticals, healthcare, and other sectors. Furthermore, the increase in awareness of the advantages of native collagen for elderly people due to pandemic outbreak have led to increase in the demand which will have positive impact on the market during the forecast period.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the native collagen market analysis from 2021 to 2031 to identify the prevailing native collagen market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the native collagen market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global native collagen market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Source
- Bovine
- Porcine
- Poultry
- Marine
- Others
By Application
- Healthcare and Pharmaceuticals
- End Use
- Bone and Joint Reconstruction
- Wound Dressing
- Tissue Regeneration
- Others
- Cosmetics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Spain
- Rest Of Europe
- Germany
- France
- Italy
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Latin America
- Africa
- Middle East
- Key Market Players
- Creative Enzymes
- Symatese
- Vetoquinol S.A.
- Bio-Rad Laboratories, Inc.
- REPROCELL USA Inc.
- Aviva Systems Biology Corporation
- RayBiotech, Inc.
- Cosmo Bio
- Bioiberica S.A.U
- Rockland Immunochemicals Inc.
- Beyond Biopharma Co., Ltd.
- TSI GROUP
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Pricing Analysis
3.8.Value Chain Analysis
3.9.Key Regulation Analysis
CHAPTER 4: NATIVE COLLAGEN MARKET, BY SOURCE
4.1 Overview
4.1.1 Market size and forecast
4.2 Bovine
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Porcine
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Poultry
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Marine
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: NATIVE COLLAGEN MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Healthcare and Pharmaceuticals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Healthcare and Pharmaceuticals Native Collagen Market by End Use
5.2.4.1 Bone and Joint Reconstruction Market size and forecast, by region
5.2.4.2 Bone and Joint Reconstruction Market size and forecast, by country
5.2.4.3 Wound Dressing Market size and forecast, by region
5.2.4.4 Wound Dressing Market size and forecast, by country
5.2.4.5 Tissue Regeneration Market size and forecast, by region
5.2.4.6 Tissue Regeneration Market size and forecast, by country
5.2.4.7 Others Market size and forecast, by region
5.2.4.8 Others Market size and forecast, by country
5.3 Cosmetics
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: NATIVE COLLAGEN MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Source
6.2.3 North America Market size and forecast, by Application
6.2.3.1 North America Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Source
6.2.4.1.2 Market size and forecast, by Application
6.2.4.1.2.1 U.S. Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Source
6.2.4.2.2 Market size and forecast, by Application
6.2.4.2.2.1 Canada Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Source
6.2.4.3.2 Market size and forecast, by Application
6.2.4.3.2.1 Mexico Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Source
6.3.3 Europe Market size and forecast, by Application
6.3.3.1 Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Source
6.3.4.1.2 Market size and forecast, by Application
6.3.4.1.2.1 Germany Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Source
6.3.4.2.2 Market size and forecast, by Application
6.3.4.2.2.1 France Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.3 Italy
6.3.4.3.1 Market size and forecast, by Source
6.3.4.3.2 Market size and forecast, by Application
6.3.4.3.2.1 Italy Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Source
6.3.4.4.2 Market size and forecast, by Application
6.3.4.4.2.1 Spain Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Source
6.3.4.5.2 Market size and forecast, by Application
6.3.4.5.2.1 Rest of Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Source
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.3.1 Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Source
6.4.4.1.2 Market size and forecast, by Application
6.4.4.1.2.1 China Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Source
6.4.4.2.2 Market size and forecast, by Application
6.4.4.2.2.1 Japan Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Source
6.4.4.3.2 Market size and forecast, by Application
6.4.4.3.2.1 India Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Source
6.4.4.4.2 Market size and forecast, by Application
6.4.4.4.2.1 South Korea Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.5 Rest of Asia-Pacific
6.4.4.5.1 Market size and forecast, by Source
6.4.4.5.2 Market size and forecast, by Application
6.4.4.5.2.1 Rest of Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Source
6.5.3 LAMEA Market size and forecast, by Application
6.5.3.1 LAMEA Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Source
6.5.4.1.2 Market size and forecast, by Application
6.5.4.1.2.1 Latin America Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4.2 Africa
6.5.4.2.1 Market size and forecast, by Source
6.5.4.2.2 Market size and forecast, by Application
6.5.4.2.2.1 Africa Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4.3 Middle East
6.5.4.3.1 Market size and forecast, by Source
6.5.4.3.2 Market size and forecast, by Application
6.5.4.3.2.1 Middle East Healthcare and Pharmaceuticals Native Collagen Market by End Use
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Creative Enzymes
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Symatese
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Vetoquinol S.A.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 REPROCELL USA Inc.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Aviva Systems Biology Corporation
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 RayBiotech, Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Cosmo Bio
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Bioiberica S.A.U
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Rockland Immunochemicals Inc.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
8.11 Beyond Biopharma Co., Ltd.
8.11.1 Company overview
8.11.2 Company snapshot
8.11.3 Operating business segments
8.11.4 Product portfolio
8.11.5 Business performance
8.11.6 Key strategic moves and developments
8.12 TSI GROUP
8.12.1 Company overview
8.12.2 Company snapshot
8.12.3 Operating business segments
8.12.4 Product portfolio
8.12.5 Business performance
8.12.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 2. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 3. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 ($MILLION)
TABLE 4. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 (TONS)
TABLE 5. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 7. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 ($MILLION)
TABLE 8. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 (TONS)
TABLE 9. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 11. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 12. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 (TONS)
TABLE 13. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 (TONS)
TABLE 15. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 (TONS)
TABLE 17. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 19. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 21. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 23. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 25. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
TABLE 26. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 (TONS)
TABLE 27. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 (TONS)
TABLE 29. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 30. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 31. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 ($MILLION)
TABLE 32. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 (TONS)
TABLE 33. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 (TONS)
TABLE 35. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 ($MILLION)
TABLE 36. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 (TONS)
TABLE 37. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 (TONS)
TABLE 39. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 ($MILLION)
TABLE 40. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 (TONS)
TABLE 41. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 (TONS)
TABLE 43. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 44. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 45. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 47. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
TABLE 48. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 (TONS)
TABLE 49. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 50. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 (TONS)
TABLE 51. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 52. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 53. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 55. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 56. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 (TONS)
TABLE 57. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 58. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 59. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 61. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 62. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 63. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 65. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 66. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 67. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 69. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 70. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 71. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 72. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 73. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 75. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 76. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 77. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 78. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 79. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 81. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 82. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 83. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 84. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 85. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 87. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 88. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 89. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 90. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 91. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 92. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 93. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 95. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 96. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 97. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 98. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 99. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 101. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 102. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 103. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 104. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 105. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 107. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 108. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 109. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 110. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 111. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 112. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 113. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 114. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 115. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 116. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 117. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 119. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 120. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 121. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 122. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 123. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 124. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 125. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 126. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 127. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 128. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 129. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 130. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 131. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 133. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 134. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 135. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 136. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 137. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 138. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 139. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 140. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 141. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 142. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 143. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 144. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 145. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 146. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 147. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 148. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 149. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 150. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 151. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 152. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 153. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 154. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 155. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 156. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 157. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 158. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 159. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 160. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 161. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 162. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 163. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 164. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 165. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 166. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 167. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 168. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 169. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 170. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 171. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 172. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 173. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 174. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 175. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 176. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 177. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 178. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 179. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 180. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 181. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 182. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 183. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 184. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 185.CREATIVE ENZYMES: COMPANY SNAPSHOT
TABLE 186.CREATIVE ENZYMES: OPERATING SEGMENTS
TABLE 187.CREATIVE ENZYMES: PRODUCT PORTFOLIO
TABLE 188.CREATIVE ENZYMES: NET SALES,
TABLE 189.CREATIVE ENZYMES: KEY STRATERGIES
TABLE 190.SYMATESE: COMPANY SNAPSHOT
TABLE 191.SYMATESE: OPERATING SEGMENTS
TABLE 192.SYMATESE: PRODUCT PORTFOLIO
TABLE 193.SYMATESE: NET SALES,
TABLE 194.SYMATESE: KEY STRATERGIES
TABLE 195.VETOQUINOL S.A.: COMPANY SNAPSHOT
TABLE 196.VETOQUINOL S.A.: OPERATING SEGMENTS
TABLE 197.VETOQUINOL S.A.: PRODUCT PORTFOLIO
TABLE 198.VETOQUINOL S.A.: NET SALES,
TABLE 199.VETOQUINOL S.A.: KEY STRATERGIES
TABLE 200.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 201.BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 202.BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 203.BIO-RAD LABORATORIES, INC.: NET SALES,
TABLE 204.BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
TABLE 205.REPROCELL USA INC.: COMPANY SNAPSHOT
TABLE 206.REPROCELL USA INC.: OPERATING SEGMENTS
TABLE 207.REPROCELL USA INC.: PRODUCT PORTFOLIO
TABLE 208.REPROCELL USA INC.: NET SALES,
TABLE 209.REPROCELL USA INC.: KEY STRATERGIES
TABLE 210.AVIVA SYSTEMS BIOLOGY CORPORATION: COMPANY SNAPSHOT
TABLE 211.AVIVA SYSTEMS BIOLOGY CORPORATION: OPERATING SEGMENTS
TABLE 212.AVIVA SYSTEMS BIOLOGY CORPORATION: PRODUCT PORTFOLIO
TABLE 213.AVIVA SYSTEMS BIOLOGY CORPORATION: NET SALES,
TABLE 214.AVIVA SYSTEMS BIOLOGY CORPORATION: KEY STRATERGIES
TABLE 215.RAYBIOTECH, INC.: COMPANY SNAPSHOT
TABLE 216.RAYBIOTECH, INC.: OPERATING SEGMENTS
TABLE 217.RAYBIOTECH, INC.: PRODUCT PORTFOLIO
TABLE 218.RAYBIOTECH, INC.: NET SALES,
TABLE 219.RAYBIOTECH, INC.: KEY STRATERGIES
TABLE 220.COSMO BIO: COMPANY SNAPSHOT
TABLE 221.COSMO BIO: OPERATING SEGMENTS
TABLE 222.COSMO BIO: PRODUCT PORTFOLIO
TABLE 223.COSMO BIO: NET SALES,
TABLE 224.COSMO BIO: KEY STRATERGIES
TABLE 225.BIOIBERICA S.A.U: COMPANY SNAPSHOT
TABLE 226.BIOIBERICA S.A.U: OPERATING SEGMENTS
TABLE 227.BIOIBERICA S.A.U: PRODUCT PORTFOLIO
TABLE 228.BIOIBERICA S.A.U: NET SALES,
TABLE 229.BIOIBERICA S.A.U: KEY STRATERGIES
TABLE 230.ROCKLAND IMMUNOCHEMICALS INC.: COMPANY SNAPSHOT
TABLE 231.ROCKLAND IMMUNOCHEMICALS INC.: OPERATING SEGMENTS
TABLE 232.ROCKLAND IMMUNOCHEMICALS INC.: PRODUCT PORTFOLIO
TABLE 233.ROCKLAND IMMUNOCHEMICALS INC.: NET SALES,
TABLE 234.ROCKLAND IMMUNOCHEMICALS INC.: KEY STRATERGIES
TABLE 235.BEYOND BIOPHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 236.BEYOND BIOPHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 237.BEYOND BIOPHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 238.BEYOND BIOPHARMA CO., LTD.: NET SALES,
TABLE 239.BEYOND BIOPHARMA CO., LTD.: KEY STRATERGIES
TABLE 240.TSI GROUP: COMPANY SNAPSHOT
TABLE 241.TSI GROUP: OPERATING SEGMENTS
TABLE 242.TSI GROUP: PRODUCT PORTFOLIO
TABLE 243.TSI GROUP: NET SALES,
TABLE 244.TSI GROUP: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.NATIVE COLLAGEN MARKET SEGMENTATION
FIGURE 2.NATIVE COLLAGEN MARKET,2021-2031
FIGURE 3.NATIVE COLLAGEN MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.NATIVE COLLAGEN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PRICING ANALYSIS
FIGURE 13.VALUE CHAIN ANALYSIS
FIGURE 14.KEY REGULATION ANALYSIS
FIGURE 15.NATIVE COLLAGEN MARKET,BY SOURCE,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BOVINE NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PORCINE NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF POULTRY NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MARINE NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 21.NATIVE COLLAGEN MARKET,BY APPLICATION,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF COSMETICS NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS NATIVE COLLAGEN MARKET,2021-2031(%)
FIGURE 25.NATIVE COLLAGEN MARKET BY REGION,2021
FIGURE 26.U.S. NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 27.CANADA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 28.MEXICO NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 29.GERMANY NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 30.FRANCE NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 31.ITALY NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 32.SPAIN NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 33.REST OF EUROPE NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 34.CHINA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 35.JAPAN NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 36.INDIA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 37.SOUTH KOREA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 38.REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 39.LATIN AMERICA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 40.AFRICA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 41.MIDDLE EAST NATIVE COLLAGEN MARKET,2021-2031($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46.COMPETITIVE DASHBOARD
FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48.CREATIVE ENZYMES.: NET SALES ,($MILLION)
FIGURE 49.SYMATESE.: NET SALES ,($MILLION)
FIGURE 50.VETOQUINOL S.A..: NET SALES ,($MILLION)
FIGURE 51.BIO-RAD LABORATORIES, INC..: NET SALES ,($MILLION)
FIGURE 52.REPROCELL USA INC..: NET SALES ,($MILLION)
FIGURE 53.AVIVA SYSTEMS BIOLOGY CORPORATION.: NET SALES ,($MILLION)
FIGURE 54.RAYBIOTECH, INC..: NET SALES ,($MILLION)
FIGURE 55.COSMO BIO.: NET SALES ,($MILLION)
FIGURE 56.BIOIBERICA S.A.U.: NET SALES ,($MILLION)
FIGURE 57.ROCKLAND IMMUNOCHEMICALS INC..: NET SALES ,($MILLION)
FIGURE 58.BEYOND BIOPHARMA CO., LTD..: NET SALES ,($MILLION)
FIGURE 59.TSI GROUP.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security